Development of transdermal therapeutic formulation of CNS5161, a novel N-methyl-D-aspartate receptor antagonist, by utilizing pressure-sensitive adhesives I

Medicine & Life Sciences

• acrylic acid 96%
• Styrene 83%
• N-Methyl-D-Aspartate Receptors 66%
• Adhesives 62%
• Silicones 48%
• isoprene 48%
• Pressure 43%
• Permeability 19%
• Therapeutics 10%
• Skin Absorption 9%
• Thermodynamics 9%
• Hydroxyl Radical 8%
• Neuralgia 7%
• Nervous System Diseases 6%
• Skin 4%

Chemical Compounds

• N Methyl Dextro Aspartic Acid Receptor Blocking Agent 100%
• Transdermal 86%
• Acrylate 59%
• Permeability 17%
• Styrene 11%
• Activity (Thermodynamic) 10%
• Percutaneous 10%
• Disorder 6%